Drug: lenalidomide Quarter: 2016Q3
Total Records: 280 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| lenalidomide | Disease progression | 6 |
| lenalidomide | Liver function test abnormal | 5 |
| LENALIDOMIDE | Drug ineffective | 4 |
| lenalidomide | Infection | 4 |
| LENALIDOMIDE | Lymphocytic leukaemia | 4 |
| LENALIDOMIDE | Urinary tract infection | 4 |
| LENALIDOMIDE (CC-5013) | Neutropenia | 4 |
| lenalidomide | Administration site reaction | 3 |
| lenalidomide | Blood creatinine increased | 3 |
| LENALIDOMIDE | Bone disorder | 3 |
| lenalidomide | Confusional state | 3 |
| Lenalidomide | Delirium | 3 |
| LENALIDOMIDE | Drug intolerance | 3 |
| lenalidomide | Haemorrhage | 3 |
| LENALIDOMIDE | Hypercalcaemia | 3 |
| lenalidomide | Investigation | 3 |
| LENALIDOMIDE | Malignant neoplasm progression | 3 |
| lenalidomide | Myocardial infarction | 3 |
| LENALIDOMIDE | Primary mediastinal large B-cell lymphoma recurrent | 3 |
| LENALIDOMIDE | Septic shock | 3 |
Total Records: 280 Number of Pages: 14